Arcus Biosciences, Inc. RCUS
18.39 USD +0.70 (+3.96%)
Nov 6, 2026, 2:22 PM EST
17.69 Day range 18.45
17.43 52-week range 31.74
- YTD
- -22.83%
- 1 year
- -5.98%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 247.00M | 258.00M | 117.00M | 112.00M | 383.00M | |
| 247.00M | 258.00M | 117.00M | 112.00M | 383.00M | |
| -386.00M | -330.00M | -340.00M | -280.00M | 54.00M | |
| -353.00M | -283.00M | -307.00M | -267.00M | 53.00M | |
| -3.29 | -3.14 | -4.15 | -3.71 | 0.71 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 222.00M | 150.00M | 127.00M | 206.00M | 148.00M | |
| 1.14B | 1.15B | 1.09B | 1.34B | 1.59B | |
| 508.00M | 665.00M | 633.00M | 688.00M | 750.00M | |
| 99.00M | 48.00M | 0 | 0 | 0 | |
| 631.00M | 485.00M | 462.00M | 657.00M | 842.00M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -482.00M | -170.00M | -306.00M | 438.00M | -256.00M | |
| 66.00M | -84.00M | 194.00M | -413.00M | -4.00M | |
| 488.00M | 277.00M | 33.00M | 33.00M | 237.00M | |
| -2.00M | -6.00M | -24.00M | -6.00M | -26.00M | |
| 72.00M | 23.00M | -79.00M | 58.00M | -23.00M |